ToxStrategies Acquires Modality Solutions
ToxStrategies LLC is excited to announce that Modality Solutions is joining forces with our firm, greatly expanding our ability to serve the evolving needs of… read more
Latest News
EpidStrategies scientists present at ICPE 2023, Halifax Nova Scotia, August 23-27
EpidStrategies is excited to be attending and presenting at The International Society for Pharmacoepidemiology’s (ISPE) 39th Annual Meeting (ICPE 2023), August 23rd through… read more
Dr. Rayetta Henderson will provide witness testimony during the “Hemp in the Modern World: The Yearslong Wait for FDA Action” hearing to be held on July 27, 2023.
Dr. Rayetta Henderson will provide witness testimony during the “Hemp in the Modern World: The Yearslong Wait for FDA Action” hearing to be… read more
EpidStrategies’ Cara Frankenfeld will be at the American Society for Nutrition’s Annual Meeting, Nutrition 2023, in Boston, July 22-25
Dr. Frankenfeld is an expert in nutritional epidemiology research and has conducted primary data collection research and secondary data analysis using population-based data… read more
New Food Safety Books Feature Food Defense
ToxStrategies food defense expert Dr. Jennifer van de Ligt and co-author Ned Mitenius have written chapters on food defense that are included in… read more
EpidStrategies’ Naomi Sacks is at ISPOR
Dr. Sacks is a co-author on four poster presentations at the annual meeting of ISPOR (The Professional Society for Health Economics and Outcomes… read more
Scientists from EpidStrategies are attending ISPOR 2023 in Boston!
Scientists from EpidStrategies are attending ISPOR 2023 in Boston! Please reach out and connect with us and meet the newest addition to our… read more
ToxStrategies scientists publish pre-clinical toxicity studies on cannabidiol (CBD)
ToxStrategies scientists have published two manuscripts in Food and Chemical Toxicology reporting the study design and outcome of 14- and 90-day repeat-dose oral… read more